Skip to main content
Erschienen in: Inflammation 3/2013

01.06.2013

p-Cymene Modulates In Vitro and In Vivo Cytokine Production by Inhibiting MAPK and NF-κB Activation

verfasst von: Weiting Zhong, Gefu Chi, Lanxiang Jiang, Lanan Wassy Soromou, Na Chen, Meixia Huo, Weixiao Guo, Xuming Deng, Haihua Feng

Erschienen in: Inflammation | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The present study was designed to investigate the effects of p-cymene on lipopolysaccharide (LPS)-induced inflammatory cytokine production both in vitro and in vivo. The production of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and interleukin-10 (IL-10) in LPS-stimulated RAW 264.7 cells and C57BL/6 mice was evaluated by sandwich ELISA. Meanwhile, the mRNA levels of cytokine genes were examined in vitro by semiquantitative RT-PCR. In a further study, we analyzed the activation of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways by western blotting. We found that p-cymene significantly regulated TNF-α, IL-1β, and IL-6 production in LPS-stimulated RAW 264.7 cells. Furthermore, the levels of relative mRNAs were also found to be downregulated. In in vivo trail, p-cymene markedly suppressed the production of TNF-α and IL-1β and increased IL-10 secretion. We also found that p-cymene inhibited LPS-induced activation of extracellular signal receptor-activated kinase 1/2, p38, c-Jun N-terminal kinase, and IκBα. These results suggest that p-cymene may have a potential anti-inflammatory action on cytokine production by blocking NF-κB and MAPK signaling pathways.
Literatur
1.
Zurück zum Zitat Bone, R.C., C.J. Grodzin, and R.A. Balk. 1997. Sepsis, a new hypothesis for pathogenesis of the disease process. Chest 112: 235–243.PubMedCrossRef Bone, R.C., C.J. Grodzin, and R.A. Balk. 1997. Sepsis, a new hypothesis for pathogenesis of the disease process. Chest 112: 235–243.PubMedCrossRef
2.
Zurück zum Zitat Glauser, M.P., D. Heumann, J.D. Baumgartner, and J. Cohen. 1994. Pathogenesis and potential strategies for prevention and treatment of septic shock: An update. Clinical Infectious Diseases 2: 205–216.CrossRef Glauser, M.P., D. Heumann, J.D. Baumgartner, and J. Cohen. 1994. Pathogenesis and potential strategies for prevention and treatment of septic shock: An update. Clinical Infectious Diseases 2: 205–216.CrossRef
3.
Zurück zum Zitat Adams, D.O. 1994. Molecular biology of macrophage activation: A pathway whereby psychosocial factors can potentially affect health. Psychosomatic Medicine 56: 316–327.PubMed Adams, D.O. 1994. Molecular biology of macrophage activation: A pathway whereby psychosocial factors can potentially affect health. Psychosomatic Medicine 56: 316–327.PubMed
4.
Zurück zum Zitat Morrison, D.C., and J.L. Ryan. 1987. Endotoxin and disease mechanisms. Annual Review of Medicine 38: 417–432.PubMedCrossRef Morrison, D.C., and J.L. Ryan. 1987. Endotoxin and disease mechanisms. Annual Review of Medicine 38: 417–432.PubMedCrossRef
5.
Zurück zum Zitat Porter, K.J., B. Gonipeta, S. Parvataneni, and D. Appledorn. 2010. M. Patial S. Sharma D, et al. Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. Journal of Cellular Physiology 225: 406–416.PubMedCrossRef Porter, K.J., B. Gonipeta, S. Parvataneni, and D. Appledorn. 2010. M. Patial S. Sharma D, et al. Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. Journal of Cellular Physiology 225: 406–416.PubMedCrossRef
6.
7.
Zurück zum Zitat Guha, M., M.A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S.F. Yan, et al. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98: 1429–1439.PubMedCrossRef Guha, M., M.A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S.F. Yan, et al. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98: 1429–1439.PubMedCrossRef
8.
Zurück zum Zitat Hall, A.J., H.L. Vos, and R.M. Bertina. 1999. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappa B nuclear translocation. Journal of Biological Chemistry 274: 376–383.PubMedCrossRef Hall, A.J., H.L. Vos, and R.M. Bertina. 1999. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappa B nuclear translocation. Journal of Biological Chemistry 274: 376–383.PubMedCrossRef
9.
Zurück zum Zitat Hambleton, J., S.L. Weinstein, L. Lem, and A.L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proceedings of the National Academy of Sciences of the United States of America 93: 2774–2778.PubMedCrossRef Hambleton, J., S.L. Weinstein, L. Lem, and A.L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proceedings of the National Academy of Sciences of the United States of America 93: 2774–2778.PubMedCrossRef
10.
Zurück zum Zitat Cavalli, J.F., F. Tomi, A.F. Bernardini, and J. Casanova. 2004. Combined analysis of the essential oil of Chenopodium ambrosioides by GC, GC-MS and 13C-NMR spectroscopy: Quantitative determination of ascaridole, a heat-sensitive compound. Phytochemical Analysis 15: 275–279.PubMedCrossRef Cavalli, J.F., F. Tomi, A.F. Bernardini, and J. Casanova. 2004. Combined analysis of the essential oil of Chenopodium ambrosioides by GC, GC-MS and 13C-NMR spectroscopy: Quantitative determination of ascaridole, a heat-sensitive compound. Phytochemical Analysis 15: 275–279.PubMedCrossRef
11.
Zurück zum Zitat Khokra, S.L., O. Prakash, S. Jain, K.R. Aneja, and Y. Dhingra. 2008. Essential oil composition and antibacterial studies of Vitex negundo Linn. extracts. Indian Journal of Pharmaceutical Sciences 70: 522–526.PubMedCrossRef Khokra, S.L., O. Prakash, S. Jain, K.R. Aneja, and Y. Dhingra. 2008. Essential oil composition and antibacterial studies of Vitex negundo Linn. extracts. Indian Journal of Pharmaceutical Sciences 70: 522–526.PubMedCrossRef
12.
Zurück zum Zitat Alma, M.H., A. Mavi, A. Yildirim, M. Digrak, and T. Hirata. 2003. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biological and Pharmaceutical Bulletin 26: 1725–1729.PubMedCrossRef Alma, M.H., A. Mavi, A. Yildirim, M. Digrak, and T. Hirata. 2003. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biological and Pharmaceutical Bulletin 26: 1725–1729.PubMedCrossRef
13.
Zurück zum Zitat Raza, M., A.A. Alghasham, M.S. Alorainy, and T.M. El-Hadiyah. 2008. Potentiation of valproate-induced anticonvulsant response by Nigella sativa seed constituents: The role of GABA receptors. International Journal of Health Sciences 2: 15–25.PubMed Raza, M., A.A. Alghasham, M.S. Alorainy, and T.M. El-Hadiyah. 2008. Potentiation of valproate-induced anticonvulsant response by Nigella sativa seed constituents: The role of GABA receptors. International Journal of Health Sciences 2: 15–25.PubMed
14.
Zurück zum Zitat Zhang, X., Y. Song, X. Ci, N. An, J. Fan, J. Cui, et al. 2008. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. International Immunopharmacology 8: 982–988.PubMedCrossRef Zhang, X., Y. Song, X. Ci, N. An, J. Fan, J. Cui, et al. 2008. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. International Immunopharmacology 8: 982–988.PubMedCrossRef
15.
Zurück zum Zitat Remick, D.G., R.G. Kunkel, J.K. Larrick, and S.L. Kunkel. 1987. Acute in vivo effects of human recombinant tumor necrosis factor. Laboratory Investigation 56: 583–590.PubMed Remick, D.G., R.G. Kunkel, J.K. Larrick, and S.L. Kunkel. 1987. Acute in vivo effects of human recombinant tumor necrosis factor. Laboratory Investigation 56: 583–590.PubMed
16.
Zurück zum Zitat Beutler, B., and A. Cerami. 1988. Tumor necrosis, cachexia, shock, and inflammation: A common mediator. Annual Review of Biochemistry 57: 505–518.PubMedCrossRef Beutler, B., and A. Cerami. 1988. Tumor necrosis, cachexia, shock, and inflammation: A common mediator. Annual Review of Biochemistry 57: 505–518.PubMedCrossRef
18.
Zurück zum Zitat Hack, C.E., E.R. De Groot, R.J. Felt-Bersma, J.H. Nuijens, R.J. Strack Van Schijndel, A.J. Eerenberg-Belmer, et al. 1989. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704–1710.PubMed Hack, C.E., E.R. De Groot, R.J. Felt-Bersma, J.H. Nuijens, R.J. Strack Van Schijndel, A.J. Eerenberg-Belmer, et al. 1989. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704–1710.PubMed
19.
Zurück zum Zitat Okusawa, S., J.A. Gelfand, T. Ikejima, R.J. Connolly, and C.A. Dinarello. 1988. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. The Journal of Clinical Investigation 81: 1162–1172.PubMedCrossRef Okusawa, S., J.A. Gelfand, T. Ikejima, R.J. Connolly, and C.A. Dinarello. 1988. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. The Journal of Clinical Investigation 81: 1162–1172.PubMedCrossRef
20.
Zurück zum Zitat Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355–337.PubMedCrossRef Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355–337.PubMedCrossRef
21.
Zurück zum Zitat Nijsten, M.W., E.R. de Groot, H.J. ten Duis, H.J. Klasen, C.E. Hack, and L.A. Aarden. 1987. Serum levels of intenleukin-6 and acute phase responses. Lancet 2: 921.PubMedCrossRef Nijsten, M.W., E.R. de Groot, H.J. ten Duis, H.J. Klasen, C.E. Hack, and L.A. Aarden. 1987. Serum levels of intenleukin-6 and acute phase responses. Lancet 2: 921.PubMedCrossRef
22.
Zurück zum Zitat Helle, M., J.P. Brakenhoff, E.R. De Groot, and L.A. Aarden. 1988. Interleukin 6 is involved in interleukin-1-induced activities. European Journal of Immunology 18: 957–959.PubMedCrossRef Helle, M., J.P. Brakenhoff, E.R. De Groot, and L.A. Aarden. 1988. Interleukin 6 is involved in interleukin-1-induced activities. European Journal of Immunology 18: 957–959.PubMedCrossRef
23.
Zurück zum Zitat Hack, C.E., E.R. De Groot, R.J. Felt-Bersma, and J.H. Nuijens. 1989. Strack Van Schijndel RJ, Eerenberg-Belmer AJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704–1710.PubMed Hack, C.E., E.R. De Groot, R.J. Felt-Bersma, and J.H. Nuijens. 1989. Strack Van Schijndel RJ, Eerenberg-Belmer AJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704–1710.PubMed
24.
Zurück zum Zitat Walley, K.R., N.W. Lukacs, T.J. Standiford, R.M. Strieter, and S.L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infection and Immunity 64: 4733–4738.PubMed Walley, K.R., N.W. Lukacs, T.J. Standiford, R.M. Strieter, and S.L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infection and Immunity 64: 4733–4738.PubMed
25.
Zurück zum Zitat de Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. The Journal of Experimental Medicine 174: 1209–1220.PubMedCrossRef de Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. The Journal of Experimental Medicine 174: 1209–1220.PubMedCrossRef
26.
Zurück zum Zitat Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147: 3815–3822. Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147: 3815–3822.
27.
Zurück zum Zitat Gerard, C.C., A. Bruyns, D. Marchant, P. Abramowicz, A. Vandenabeele, W. Delvaux, et al. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. The Journal of Experimental Medicine 177: 547–550.PubMedCrossRef Gerard, C.C., A. Bruyns, D. Marchant, P. Abramowicz, A. Vandenabeele, W. Delvaux, et al. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. The Journal of Experimental Medicine 177: 547–550.PubMedCrossRef
28.
Zurück zum Zitat Marchant, A.C., P. Bruyns, M. Vandenabeele, C. Ducarme, A. Gerard, D. Delvaux, et al. 1994. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. European Journal of Immunology 24: 1167–1171.PubMedCrossRef Marchant, A.C., P. Bruyns, M. Vandenabeele, C. Ducarme, A. Gerard, D. Delvaux, et al. 1994. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. European Journal of Immunology 24: 1167–1171.PubMedCrossRef
29.
Zurück zum Zitat Takeuchi, O., S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, et al. 2002. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. The Journal of Immunology 169: 10–14.PubMed Takeuchi, O., S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, et al. 2002. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. The Journal of Immunology 169: 10–14.PubMed
30.
Zurück zum Zitat Su, H., N. Bidère, L. Zheng, A. Cubre, K. Sakai, J. Dale, et al. 2005. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307: 1465–1468.PubMedCrossRef Su, H., N. Bidère, L. Zheng, A. Cubre, K. Sakai, J. Dale, et al. 2005. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307: 1465–1468.PubMedCrossRef
31.
Zurück zum Zitat van der Bruggen, T., S. Nijenhuis, E. van Raaij, J. Verhoef, and B.S. van Asbeck. 1999. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infection and Immunity 67: 3824–3829.PubMed van der Bruggen, T., S. Nijenhuis, E. van Raaij, J. Verhoef, and B.S. van Asbeck. 1999. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infection and Immunity 67: 3824–3829.PubMed
32.
Zurück zum Zitat Andersson, K., and R. Sundler. 2000. Signaling to translational activation of tumour necrosis factor-alpha expression in human THP-1 cells. Cytokine 12: 1784–1787.PubMedCrossRef Andersson, K., and R. Sundler. 2000. Signaling to translational activation of tumour necrosis factor-alpha expression in human THP-1 cells. Cytokine 12: 1784–1787.PubMedCrossRef
33.
Zurück zum Zitat Xagorari, A., C. Roussos, and A. Papapetropoulos. 2002. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. British Journal of Pharmacology 136: 1058–1064.PubMedCrossRef Xagorari, A., C. Roussos, and A. Papapetropoulos. 2002. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. British Journal of Pharmacology 136: 1058–1064.PubMedCrossRef
34.
Zurück zum Zitat Swantek, J.L., M.H. Cobb, and T.D. Geppert. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Molecular and Cellular Biology 17: 6274–6282.PubMed Swantek, J.L., M.H. Cobb, and T.D. Geppert. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Molecular and Cellular Biology 17: 6274–6282.PubMed
35.
Zurück zum Zitat Carter, A.B., M.M. Monick, and G.W. Hunninghake. 1999. Both Erk and p38 kinases are necessary for cytokine gene transcription. American Journal of Respiratory Cell and Molecular Biology 20: 751–758.PubMedCrossRef Carter, A.B., M.M. Monick, and G.W. Hunninghake. 1999. Both Erk and p38 kinases are necessary for cytokine gene transcription. American Journal of Respiratory Cell and Molecular Biology 20: 751–758.PubMedCrossRef
36.
Zurück zum Zitat Ajizian, S.J., B.K. English, and E.A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ. Journal of Infectious Diseases 179: 939–944.PubMedCrossRef Ajizian, S.J., B.K. English, and E.A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ. Journal of Infectious Diseases 179: 939–944.PubMedCrossRef
37.
Zurück zum Zitat Mlienhard, S., A. Marcos, and A. Patrick. 1995. Transactivation domain 2 (TA2) of NF-κB p65. The Journal of Biological Chemistry 270: 15576–15584.CrossRef Mlienhard, S., A. Marcos, and A. Patrick. 1995. Transactivation domain 2 (TA2) of NF-κB p65. The Journal of Biological Chemistry 270: 15576–15584.CrossRef
38.
Zurück zum Zitat Natarajan, M., N. Aravindan, M.L. Meltz, and T.S. Herman. 2002. Post-translational modification of I-kappa B alpha activates NF-kappa B in human monocytes exposed to 56Fe ions. Radiation and Environmental Biophysics 41: 139–44.PubMed Natarajan, M., N. Aravindan, M.L. Meltz, and T.S. Herman. 2002. Post-translational modification of I-kappa B alpha activates NF-kappa B in human monocytes exposed to 56Fe ions. Radiation and Environmental Biophysics 41: 139–44.PubMed
Metadaten
Titel
p-Cymene Modulates In Vitro and In Vivo Cytokine Production by Inhibiting MAPK and NF-κB Activation
verfasst von
Weiting Zhong
Gefu Chi
Lanxiang Jiang
Lanan Wassy Soromou
Na Chen
Meixia Huo
Weixiao Guo
Xuming Deng
Haihua Feng
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9574-y

Weitere Artikel der Ausgabe 3/2013

Inflammation 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.